Key takeaways:
- The 5th U.S. Circuit Court of Appeals in New Orleans will hear arguments Wednesday regarding the future availability of the abortion pill mifepristone.
- More than five million women in the United States have used mifepristone to terminate their pregnancies, as have millions of other women around the world.
- The outcome of the case could have a major impact on the availability of the drug and could affect the lives of millions of women around the world.
The legal battle over the abortion pill mifepristone is set to reach a new level as a conservative federal appeals court in New Orleans is scheduled to hear arguments Wednesday. The case could decide the future availability of the drug, which is now the most commonly used abortion pill in the U.S.
Attorneys for the Food and Drug Administration and the drug’s manufacturer will attempt to convince a three-judge panel of the 5th U.S. Circuit Court of Appeals in New Orleans not to roll back accessibility to mifepristone. The panel consists of Jennifer Walker Elrod, James Ho and Cory Wilson.
The case is one of the most significant involving abortion rights in the wake of the Supreme Court’s decision last June that reversed the constitutional right to abortion. More than five million women in the United States have used mifepristone to terminate their pregnancies, as have millions of other women around the world.
The FDA’s filing states that serious adverse events are exceedingly rare. The outcome of the case could have a major impact on the availability of the drug, with the potential to disrupt its availability nationwide.
The court will hear arguments Wednesday and a decision is expected in the coming weeks. The outcome of the case could have a major impact on the availability of the drug and could affect the lives of millions of women around the world.
Be First to Comment